Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/1999
09/01/1999EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
09/01/1999EP0938558A2 Gaba a receptor subunit epsilon-related protein
09/01/1999EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/01/1999EP0938553A1 Dna encoding dp. 75 and a process for its use
09/01/1999EP0938548A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
09/01/1999EP0938506A1 Immunoglobulin superfamily domains and fragments with increased solubility
09/01/1999EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
09/01/1999EP0938497A1 Constrained helical peptides and methods of making same
09/01/1999EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof
09/01/1999EP0938334A1 Improved method of treating immune cell mediated systemic diseases
09/01/1999EP0725833A4 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
09/01/1999EP0706655B1 Mca assay/kit for detecting metal cations
09/01/1999EP0573545B1 Monoclonal antibodies against receptor-induced binding sites
09/01/1999CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections
09/01/1999CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
09/01/1999CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses
09/01/1999CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus
09/01/1999CN1227497A Purified sperm surface antigen, monoclonal antibody therefor and application therefor
09/01/1999CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell
09/01/1999CN1044911C Method for preparing prodrug
08/1999
08/31/1999US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents
08/31/1999US5945512 An antibody against amino-terminated peptide for the detection of diabetic vascular disorders
08/31/1999US5945511 Class II cytokine receptor
08/31/1999US5945509 A polypeptide that codes for a membrane protein involved in neurotransmission; therapy and diagnosis of nervous systemdisorders
08/31/1999US5945505 Human phospholemman-like protein
08/31/1999US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
08/31/1999US5945330 Polynucleotide
08/31/1999US5945311 Fusing two antibody hybridomas, into a quadroma, culturing and mutiplying the quadroma, applying culture supernatant to column, eluting antibodies at a ph value for the antibody with the greatest affinity for protein a
08/31/1999US5945310 DNA encoding members of the IL-1 family, IL-1 delta
08/31/1999US5945308 Polynucleotide
08/31/1999US5945307 Nucleotide sequences that code a protein expressed in the brain and belonging to the 5-hydroxytryptamine receptor family; gene therapy, screening of drugs and genetic disorders, diagnostic assays
08/31/1999US5945296 An antibody that specifically binds an isoform of human growth hormone and can be used for accurateimmunoassays measurement of human growth hormone in bodily fluids
08/31/1999US5945274 Quantitative analysis of free lysylpyridinoline in a urine sample and correlating it to bone resorption in vivo wherein urine sample is hydrolyzed
08/31/1999US5945105 Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE)
08/31/1999US5945096 Administering to the human for suppressing a human immune response to an antigen, an effective amount of antigen non-specific human glycosylation inhibiting factor
08/31/1999CA2218755C Monoclonal antibody to human beta 2 integrin alpha subunit
08/26/1999WO1999042839A2 Treating cancer
08/26/1999WO1999042837A1 Treating cancer
08/26/1999WO1999042836A1 Treating cancer
08/26/1999WO1999042835A1 Treating cancer
08/26/1999WO1999042834A2 Treating cancer
08/26/1999WO1999042830A1 Methods using pla2 as a marker of metastases and for the diagnosis of selected cancers
08/26/1999WO1999042828A2 Treating cancer
08/26/1999WO1999042821A2 Treating cancer
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999WO1999042596A2 Phosphodiesterase 10
08/26/1999WO1999042588A2 Group b streptococcus antigens
08/26/1999WO1999042586A2 Exo1 and exo2, exocytotic proteins
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042583A1 Connective tissue growth factor homologs
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042576A1 Cerebellin-2 related polypeptides and dna coding therefor
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999WO1999042562A1 NOVEL pgsA
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042484A1 Fishboy, a g-protein coupled receptor
08/26/1999WO1999042480A1 Analgesic peptides from venom of grammostola spatulata and use thereof
08/26/1999WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042140A1 Detector molecule for use in a method for detecting and surgically removing lymphoid tissue involved in tumor progression
08/26/1999WO1999042133A1 Inhibitors of complement activation
08/26/1999WO1999042132A1 Use of anti-cd44 monoclonal antibody to enhance wound healing
08/26/1999WO1999042131A1 Skin care compositions
08/26/1999WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042118A2 Compounds and methods for diagnosis of tuberculosis
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042077A2 Compositions and methods for regulating lymphocyte activation
08/26/1999WO1999042075A2 Antibodies against human cd40
08/26/1999WO1999031229A3 Peptides and nucleic acids derived from eisenia foetida and the use thereof
08/26/1999WO1999029906A3 Gene family with transformation modulating activity
08/26/1999WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/26/1999WO1999029720A3 Mammalian alpha helical protein-1
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999025375A3 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999DE19835633C1 Animal or human tumor cells which express immunoglobulins
08/26/1999DE19807389A1 New monoclonal antibodies, useful for diagnosing gynecological cancers
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2322617A1 Compounds and methods for diagnosis of tuberculosis
08/26/1999CA2321482A1 Treating cancer
08/26/1999CA2321481A1 Treating cancer
08/26/1999CA2321480A1 Treating cancer
08/26/1999CA2321479A1 Treating cancer
08/26/1999CA2321467A1 Treating cancer
08/26/1999CA2321458A1 Treating cancer
08/26/1999CA2321438A1 Treating cancer
08/26/1999CA2321262A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999CA2321224A1 Phosphodiesterase 10
08/26/1999CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999CA2321199A1 Compositions and methods for regulating lymphocyte activation
08/26/1999CA2321186A1 Apoptosis inducing molecule ii and methods of use
08/26/1999CA2321176A1 Connective tissue growth factor homologs
08/26/1999CA2321165A1 Antibodies against human cd40
08/26/1999CA2321140A1 Inhibitors of complement activation
1 ... 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 ... 1494